{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:25:29Z","timestamp":1778613929170,"version":"3.51.4"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T00:00:00Z","timestamp":1315267200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0022842","type":"journal-article","created":{"date-parts":[[2011,9,6]],"date-time":"2011-09-06T17:17:05Z","timestamp":1315329425000},"page":"e22842","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":146,"title":["Human Tumour Immune Evasion via TGF-\u03b2 Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity"],"prefix":"10.1371","volume":"6","author":[{"given":"Erica B.","family":"Wilson","sequence":"first","affiliation":[]},{"given":"Jehan J.","family":"El-Jawhari","sequence":"additional","affiliation":[]},{"given":"Abbie L.","family":"Neilson","sequence":"additional","affiliation":[]},{"given":"Geoffrey D.","family":"Hall","sequence":"additional","affiliation":[]},{"given":"Alan A.","family":"Melcher","sequence":"additional","affiliation":[]},{"given":"Josephine L.","family":"Meade","sequence":"additional","affiliation":[]},{"given":"Graham P.","family":"Cook","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2011,9,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","article-title":"Natural Innate and Adaptive Immunity to Cancer.","volume":"29","author":"MD Vesely","year":"2011","journal-title":"Annu Rev Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation.","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1038\/onc.2008.271","article-title":"The tumor microenvironment and its role in promoting tumor growth.","volume":"27","author":"TL Whiteside","year":"2008","journal-title":"Oncogene"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0065-2776(06)90002-9","article-title":"Mechanisms of immune evasion by tumors.","volume":"90","author":"CG Drake","year":"2006","journal-title":"Adv Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance.","volume":"27","author":"I Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4049\/jimmunol.171.12.6891","article-title":"Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma.","volume":"171","author":"ES Doubrovina","year":"2003","journal-title":"J Immunol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/ni1239","article-title":"Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance.","volume":"6","author":"DE Oppenheim","year":"2005","journal-title":"Nat Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.4049\/jimmunol.1000951","article-title":"A human NK cell activation\/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells.","volume":"186","author":"TD Holmes","year":"2011","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nri2604","article-title":"Oncogenic stress sensed by the immune system: role of natural killer cell receptors.","volume":"9","author":"DH Raulet","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood-2005-08-027979","article-title":"Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.","volume":"109","author":"C Fauriat","year":"2007","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.4049\/jimmunol.0901226","article-title":"Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells.","volume":"183","author":"M Carlsten","year":"2009","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1158\/0008-5472.CAN-06-2264","article-title":"DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.","volume":"67","author":"M Carlsten","year":"2007","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.4049\/jimmunol.175.9.5790","article-title":"NK cells infiltrating a MHC class I-deficient lung adenocarcinoma display impaired cytotoxic activity toward autologous tumor cells associated with altered NK cell-triggering receptors.","volume":"175","author":"B Le Maux Chansac","year":"2005","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGFbeta.","volume":"10","author":"RA Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease.","volume":"12","author":"L Gorelik","year":"2000","journal-title":"Immunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2853","article-title":"TGFbeta signalling: a complex web in cancer progression.","volume":"10","author":"H Ikushima","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7596","DOI":"10.1158\/0008-5472.CAN-04-1627","article-title":"RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo.","volume":"64","author":"MA Friese","year":"2004","journal-title":"Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.172.12.7335","article-title":"Elevated TGF-beta1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients.","volume":"172","author":"JC Lee","year":"2004","journal-title":"J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.lungcan.2007.07.022","article-title":"Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.","volume":"59","author":"G Esendagli","year":"2008","journal-title":"Lung Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1001-1118","article-title":"Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.","volume":"7","author":"L Gorelik","year":"2001","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells.","volume":"100","author":"R Castriconi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.4049\/jimmunol.181.6.3784","article-title":"TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.","volume":"181","author":"R Trotta","year":"2008","journal-title":"J Immunol"},{"key":"ref23","first-page":"570","article-title":"TGF beta down-regulates TLiSA1 expression and inhibits the differentiation of precursor lymphocytes into CTL and LAK cells.","volume":"66","author":"B Jin","year":"1989","journal-title":"Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance.","volume":"8","author":"DA Thomas","year":"2005","journal-title":"Cancer Cell"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.","volume":"8","author":"B Schmierer","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1126\/science.285.5428.730","article-title":"An activating immunoreceptor complex formed by NKG2D and DAP10.","volume":"285","author":"J Wu","year":"1999","journal-title":"Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1182\/blood-2001-12-0293","article-title":"In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells.","volume":"100","author":"MA Cooper","year":"2002","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1084\/jem.20021847","article-title":"In vivo survival and homeostatic proliferation of natural killer cells.","volume":"197","author":"M Prlic","year":"2003","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/ni1487","article-title":"Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1.","volume":"8","author":"ND Huntington","year":"2007","journal-title":"Nat Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.immuni.2009.04.020","article-title":"Opposing effects of TGF-beta and IL-15 cytokines control the number of short-lived effector CD8+ T cells.","volume":"31","author":"S Sanjabi","year":"2009","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.","volume":"96","author":"A Brunet","year":"1999","journal-title":"Cell"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0960-9822(00)00728-4","article-title":"Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.","volume":"10","author":"PF Dijkers","year":"2000","journal-title":"Curr Biol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/mol.62.1.65","article-title":"SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.","volume":"62","author":"GJ Inman","year":"2002","journal-title":"Mol Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.","volume":"31","author":"L Yang","year":"2010","journal-title":"Trends Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/neuonc\/nop009","article-title":"TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.","volume":"12","author":"CA Crane","year":"2010","journal-title":"Neuro Oncol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1038\/onc.2008.269","article-title":"Positive and negative influences of regulatory T cells on tumour immunity.","volume":"27","author":"AM Gallimore","year":"2008","journal-title":"Oncogene"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/35074122","article-title":"IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.","volume":"410","author":"V Shankaran","year":"2001","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1084\/jem.184.5.1781","article-title":"Decreased tumor surveillance in perforin-deficient mice.","volume":"184","author":"ME van den Broek","year":"1996","journal-title":"J Exp Med"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1084\/jem.20081611","article-title":"Accelerated tumor growth in mice deficient in DNAM-1 receptor.","volume":"205","author":"A Iguchi-Manaka","year":"2008","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","article-title":"NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy.","volume":"28","author":"N Guerra","year":"2008","journal-title":"Immunity"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.4049\/jimmunol.0801878","article-title":"Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46\/NCR1.","volume":"182","author":"GG Halfteck","year":"2009","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jcv.2007.10.027","article-title":"Modulation of natural killer cells by human cytomegalovirus.","volume":"41","author":"GW Wilkinson","year":"2008","journal-title":"J Clin Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"7338","DOI":"10.4049\/jimmunol.180.11.7338","article-title":"Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D.","volume":"180","author":"M Krockenberger","year":"2008","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function.","volume":"108","author":"M Della Chiesa","year":"2006","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","article-title":"Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.","volume":"182","author":"H Li","year":"2009","journal-title":"J Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/cr.2008.328","article-title":"Non-Smad pathways in TGF-beta signaling.","volume":"19","author":"YE Zhang","year":"2009","journal-title":"Cell Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1182\/blood-2008-07-166926","article-title":"Activin-A attenuates several human natural killer cell functions.","volume":"113","author":"NC Robson","year":"2009","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1158\/1078-0432.CCR-10-0700","article-title":"Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study.","volume":"16","author":"JA Konner","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8722-3-7","article-title":"Ovarian cancer immunotherapy: opportunities, progresses and challenges.","volume":"3","author":"B Liu","year":"2010","journal-title":"J Hematol Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"803","DOI":"10.4049\/jimmunol.0713829","article-title":"Proteolytic activation of the cytotoxic phenotype during human NK cell development.","volume":"183","author":"JL Meade","year":"2009","journal-title":"J Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0022842","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:39:18Z","timestamp":1540215558000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0022842"}},"subtitle":[],"editor":[{"given":"Jacques","family":"Zimmer","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2011,9,6]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2011,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0022842","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,6]]}}}